DDInter907 DDInter1082
Iloperidone is an atypical antipsychotic for the treatment of schizophrenia symptoms. Hoechst Marion Roussel Inc. researched the drug until May 1996. In June 1997 they gave the research rights to Titan Pharmaceuticals, who gave the worldwide development, manufacturing, and marketing rights to Novartis in August 1998. On June 9, 2004, Titan Pharmaceuticals gave the Phase III development rights to Vanda Pharmaceuticals. FDA approved on May 9, 2009.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Iloperidone {u} (Compound) resembles {v} (Compound) Gefitinib
Iloperidone {u} may lead to a major life threatening interaction when taken with {v} Cisapride
Iloperidone {u} (Compound) resembles {v} (Compound) Paliperidone
Iloperidone {u} (Compound) binds {v} (Gene) DRD1
Iloperidone {u} (Compound) upregulates {v} (Gene) PAK6
Iloperidone {u} (Compound) downregulates {v} (Gene) DKK3
Iloperidone {u} (Compound) causes {v} (Side Effect) Menstruation irregular
Iloperidone {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Iloperidone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Rolapitant
Iloperidone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Clidinium
Iloperidone (Compound) resembles Gefitinib (Compound)
Iloperidone may lead to a major life threatening interaction when taken with Cisapride
Iloperidone (Compound) resembles Paliperidone (Compound)
Iloperidone (Compound) binds DRD1 (Gene)
Iloperidone (Compound) upregulates PAK6 (Gene)
Iloperidone (Compound) downregulates DKK3 (Gene)
Iloperidone (Compound) causes Menstruation irregular (Side Effect)
Iloperidone may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Iloperidone may cause a moderate interaction that could exacerbate diseases when taken with Rolapitant
Iloperidone may cause a moderate interaction that could exacerbate diseases when taken with Clidinium